NEW YORK, June 5 (Reuters) - Bristol-Myers Squibb Co. and Japan's Otsuka Pharmaceutical Co. said on Tuesday that U.S. health regulators granted a priority review of their schizophrenia drug Abilify ...
NEW YORK, July 17 (Reuters) - Bristol-Myers Squibb Co. and Japan's Otsuka Pharmaceutical Co. said on Tuesday that U.S. health regulators have granted a priority review for their schizophrenia drug ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈